IRINOTECAN HYDROCHLORIDE

IRINOTECAN HYDROCHLORIDE was reported 13147 times

IRINOTECAN HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HEPATIC VENOUS PRESSURE GRADIENT ABNORMAL 8 0.7273
1 MALIGNANT CRANIAL NERVE NEOPLASM 7 0.2692
2 DESMOPLASTIC SMALL ROUND CELL TUMOUR 21 0.2414
3 VENOUS PRESSURE JUGULAR DECREASED 6 0.1579
4 RETRO-ORBITAL NEOPLASM 6 0.1132
5 STOMAL VARICES 9 0.1098
6 MALIGNANT GASTROINTESTINAL OBSTRUCTION 6 0.0714
7 NEUROBLASTOMA 26 0.0679
8 NEUROBLASTOMA RECURRENT 12 0.0591
9 CHOLINERGIC SYNDROME 33 0.0517
10 ACQUIRED TRACHEO-OESOPHAGEAL FISTULA 4 0.0506
11 BACTERIAL TRANSLOCATION 14 0.0442
12 COLONY STIMULATING FACTOR THERAPY 9 0.0435
13 TUMOUR PERFORATION 13 0.0409
14 CARBOHYDRATE ANTIGEN 19-9 INCREASED 18 0.0340
15 SUBRETINAL FLUID 37 0.0339
16 MEDULLOBLASTOMA 5 0.0336
17 PANCREATIC CARCINOMA RECURRENT 8 0.0332
18 COLORECTAL CANCER METASTATIC 77 0.0325
19 PORTAL VENOUS GAS 11 0.0303
20 CHOLANGITIS INFECTIVE 8 0.0301
21 RECTAL CANCER METASTATIC 10 0.0287
22 METASTASES TO OVARY 8 0.0251
23 COLON CANCER METASTATIC 40 0.0248
24 ADENOCARCINOMA METASTATIC 5 0.0243
25 OESOPHAGEAL MASS 5 0.0240
26 GRANULOCYTE COUNT DECREASED 43 0.0232
27 ILEAL PERFORATION 15 0.0226
28 DERMATITIS ACNEIFORM 137 0.0225
29 MUCOSAL TOXICITY 6 0.0221
30 PANCREATIC DUCT DILATATION 6 0.0218
31 COLON CANCER RECURRENT 6 0.0217
32 DUCTAL ADENOCARCINOMA OF PANCREAS 6 0.0217
33 RECTAL PERFORATION 11 0.0204
34 MYELOSUPPRESSION 719 0.0199
35 HAEMORRHOIDS THROMBOSED 6 0.0199
36 COLONIC OBSTRUCTION 5 0.0192
37 BONE MARROW DEPRESSION 18 0.0184
38 KLEBSIELLA TEST POSITIVE 12 0.0184
39 MARKEDLY REDUCED DIETARY INTAKE 9 0.0183
40 RECTAL ADENOCARCINOMA 11 0.0182
41 PROTEIN URINE 16 0.0177
42 THROMBOPHLEBITIS MIGRANS 6 0.0176
43 MALIGNANT ASCITES 13 0.0169
44 DRUG-GENETIC INTERACTION 6 0.0168
45 GLIOBLASTOMA MULTIFORME 14 0.0166
46 METASTASES TO PERITONEUM 42 0.0166
47 PARONYCHIA 71 0.0161
48 BILIARY TRACT INFECTION 10 0.0161
49 POST PROCEDURAL BILE LEAK 5 0.0160
50 PULMONARY ARTERY THROMBOSIS 12 0.0156
51 NEUTROPENIC COLITIS 32 0.0155
52 NASAL SEPTUM PERFORATION 10 0.0155
53 BILIARY OBSTRUCTION 20 0.0154
54 CHOLANGITIS 93 0.0150
55 ECTROPION 5 0.0148
56 TUMOUR NECROSIS 15 0.0142
57 STOMAL HERNIA 5 0.0136
58 PNEUMATOSIS 6 0.0135
59 CARCINOEMBRYONIC ANTIGEN INCREASED 26 0.0134
60 ENTEROCOLITIS 76 0.0132
61 GALLBLADDER PERFORATION 5 0.0130
62 GASTROENTERITIS ESCHERICHIA COLI 7 0.0128
63 SKIN CHAPPED 5 0.0124
64 DUODENAL STENOSIS 6 0.0123
65 SKIN TOXICITY 69 0.0122
66 ENTEROCOLITIS INFECTIOUS 11 0.0119
67 COLON CANCER STAGE IV 7 0.0118
68 SMALL INTESTINAL PERFORATION 22 0.0117
69 METASTASES TO PANCREAS 5 0.0113
70 STEATOHEPATITIS 6 0.0112
71 REFUSAL OF TREATMENT BY RELATIVE 5 0.0111
72 GASTROINTESTINAL TOXICITY 53 0.0110
73 NEOPLASM PROGRESSION 380 0.0109
74 RECTAL CANCER 33 0.0107
75 ENTERITIS 68 0.0106
76 LARGE INTESTINE INFECTION 13 0.0106
77 LYMPHANGIOSIS CARCINOMATOSA 11 0.0106
78 STOMA SITE HAEMORRHAGE 16 0.0104
79 PNEUMATOSIS INTESTINALIS 29 0.0102
80 PERIPHERAL SENSORY NEUROPATHY 59 0.0101
81 NECROTISING OESOPHAGITIS 5 0.0100
82 BILE DUCT STENOSIS 12 0.0100
83 LIVER ABSCESS 32 0.0099
84 NEUTROPHIL COUNT DECREASED 401 0.0098
85 TERMINAL ILEITIS 6 0.0098
86 GASTROINTESTINAL PERFORATION 40 0.0096
87 FEBRILE NEUTROPENIA 628 0.0095
88 METASTASES TO LIVER 158 0.0090
89 MYOPERICARDITIS 7 0.0090
90 LARGE INTESTINAL OBSTRUCTION 20 0.0089
91 INFECTIOUS PERITONITIS 6 0.0088
92 EASTERN COOPERATIVE ONCOLOGY GROUP PERFORMANCE STATUS WORSENED 11 0.0088
93 BLOOD CULTURE POSITIVE 26 0.0087
94 ENTERAL NUTRITION 5 0.0086
95 ESCHERICHIA BACTERAEMIA 20 0.0085
96 COLON CANCER 122 0.0082
97 ENTEROCUTANEOUS FISTULA 7 0.0079
98 ENTEROVESICAL FISTULA 6 0.0079
99 INTRA-ABDOMINAL FLUID COLLECTION 14 0.0078
100 OBSTRUCTION GASTRIC 10 0.0078
101 PERITONEAL DISORDER 5 0.0077
102 VENOOCCLUSIVE LIVER DISEASE 38 0.0077
103 TRANSPOSITION OF THE GREAT VESSELS 6 0.0077
104 PANCREATIC MASS 8 0.0075
105 PERFORATION 6 0.0074
106 CANCER PAIN 19 0.0074
107 METASTASES TO LYMPH NODES 50 0.0074
108 SUSPECTED OFF LABEL USE 33 0.0073
109 HYPOMAGNESAEMIA 101 0.0072
110 METASTASES TO LUNG 83 0.0072
111 PERIPHERAL MOTOR NEUROPATHY 10 0.0071
112 DEVICE RELATED THROMBOSIS 7 0.0071
113 HYPERAMMONAEMIA 35 0.0070
114 TREATMENT DELAYED 12 0.0069
115 EMBOLISM VENOUS 21 0.0069
116 JAW OPERATION 6 0.0067
117 BONE MARROW FAILURE 136 0.0067
118 GASTROINTESTINAL WALL THICKENING 10 0.0067
119 PORTAL VEIN THROMBOSIS 21 0.0065
120 ILEUS PARALYTIC 29 0.0065
121 STREPTOCOCCAL BACTERAEMIA 7 0.0064
122 RECTAL TENESMUS 8 0.0064
123 GASTRIC PERFORATION 17 0.0062
124 ABDOMINAL WALL ABSCESS 4 0.0062
125 SUBCLAVIAN VEIN THROMBOSIS 7 0.0061
126 MALIGNANT NEOPLASM PROGRESSION 623 0.0061
127 CAMPYLOBACTER INFECTION 5 0.0060
128 LARGE INTESTINE PERFORATION 41 0.0059
129 ACUTE PROMYELOCYTIC LEUKAEMIA 6 0.0058
130 HEPATIC HAEMORRHAGE 5 0.0058
131 HYPOALBUMINAEMIA 45 0.0058
132 MUCOSAL INFLAMMATION 151 0.0058
133 DISEASE PROGRESSION 681 0.0057
134 ILEUS 71 0.0057
135 TUMOUR HAEMORRHAGE 16 0.0056
136 METASTATIC NEOPLASM 24 0.0056
137 NEUROTOXICITY 96 0.0055
138 BILIARY DILATATION 8 0.0054
139 ENTEROCOLITIS HAEMORRHAGIC 8 0.0054
140 ADENOCARCINOMA OF COLON 10 0.0053
141 SUBILEUS 11 0.0053
142 KLEBSIELLA BACTERAEMIA 5 0.0053
143 NEPHROTIC SYNDROME 36 0.0052
144 FAILURE TO THRIVE 27 0.0052
145 HAEMATOTOXICITY 49 0.0052
146 NEUROPATHY PERIPHERAL 489 0.0051
147 URINARY TRACT OBSTRUCTION 12 0.0051
148 EMBOLISM ARTERIAL 6 0.0050
149 CULTURE URINE POSITIVE 7 0.0050
150 ORAL INTAKE REDUCED 12 0.0050
151 NEUTROPHIL COUNT ABNORMAL 14 0.0049
152 DILATED CARDIOMYOPATHY 5 0.0049
153 PHARYNGEAL INFLAMMATION 6 0.0049
154 ASCITES 145 0.0049
155 LARYNGOSPASM 13 0.0048
156 NECROTISING FASCIITIS 17 0.0048
157 PULMONARY TOXICITY 34 0.0048
158 ACUTE ABDOMEN 7 0.0048
159 MALIGNANT PLEURAL EFFUSION 8 0.0047
160 INTESTINAL PERFORATION 53 0.0047
161 ABDOMINAL INFECTION 12 0.0047
162 HICCUPS 38 0.0046
163 VARICES OESOPHAGEAL 14 0.0046
164 NEUTROPENIA 628 0.0046
165 INTERSTITIAL LUNG DISEASE 223 0.0046
166 POLYNEUROPATHY 55 0.0046
167 HYPOKALAEMIA 212 0.0046
168 HYPOVOLAEMIC SHOCK 22 0.0046
169 HYDRONEPHROSIS 34 0.0045
170 PORTAL HYPERTENSION 14 0.0045
171 PACKED RED BLOOD CELL TRANSFUSION 6 0.0045
172 JUGULAR VEIN THROMBOSIS 8 0.0045
173 METASTASES TO SPINE 15 0.0045
174 GASTROINTESTINAL STOMA COMPLICATION 7 0.0045
175 TUMOUR MARKER INCREASED 21 0.0044
176 PELVIC ABSCESS 5 0.0044
177 DISSEMINATED INTRAVASCULAR COAGULATION 61 0.0043
178 ACUTE PRERENAL FAILURE 5 0.0043
179 STOMATITIS 261 0.0043
180 PROTEINURIA 81 0.0043
181 BLOOD ELECTROLYTES DECREASED 6 0.0042
182 NOROVIRUS INFECTION 6 0.0042
183 HYPERBILIRUBINAEMIA 43 0.0041
184 WOUND DEHISCENCE 14 0.0041
185 CLOSTRIDIUM COLITIS 5 0.0041
186 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 95 0.0041
187 VASCULAR PSEUDOANEURYSM 7 0.0040
188 LEUKOPENIA 201 0.0040
189 ADENOCARCINOMA 9 0.0040
190 PERIPHERAL SENSORIMOTOR NEUROPATHY 5 0.0040
191 PRODUCT USED FOR UNKNOWN INDICATION 5 0.0040
192 SECOND PRIMARY MALIGNANCY 33 0.0040
193 INFECTIOUS PLEURAL EFFUSION 6 0.0039
194 HEPATIC LESION 17 0.0039
195 BLOOD PRESSURE IMMEASURABLE 6 0.0039
196 OESOPHAGEAL ULCER 15 0.0039
197 ADENOCARCINOMA PANCREAS 5 0.0039
198 HYPERTRANSAMINASAEMIA 27 0.0039
199 PANCREATIC CARCINOMA METASTATIC 11 0.0039
200 ABDOMINAL ABSCESS 17 0.0038
201 NEUTROPENIC SEPSIS 27 0.0038
202 GASTROINTESTINAL NECROSIS 11 0.0038
203 HYPERTRIGLYCERIDAEMIA 22 0.0038
204 INTESTINAL DILATATION 5 0.0037
205 CYSTITIS NONINFECTIVE 5 0.0037
206 RASH PUSTULAR 27 0.0037
207 HYPOPROTEINAEMIA 7 0.0037
208 JAUNDICE CHOLESTATIC 13 0.0037
209 MUCOUS MEMBRANE DISORDER 5 0.0037
210 EMBOLISM 30 0.0036
211 RECTAL ABSCESS 6 0.0036
212 INTESTINAL FISTULA 5 0.0035
213 HYPOPHAGIA 90 0.0035
214 INTENSIVE CARE 5 0.0035
215 SMALL INTESTINAL OBSTRUCTION 43 0.0035
216 LEUKOENCEPHALOPATHY 13 0.0035
217 PELVIC VENOUS THROMBOSIS 5 0.0035
218 ARTERIOSPASM CORONARY 14 0.0035
219 MALNUTRITION 39 0.0035
220 WHITE BLOOD CELL COUNT DECREASED 376 0.0035
221 RENAL INFARCT 5 0.0035
222 DEVICE RELATED INFECTION 53 0.0034
223 DUODENAL ULCER 24 0.0034
224 COLITIS 128 0.0034
225 CHOLANGIOCARCINOMA 5 0.0034
226 GRANULOCYTOPENIA 19 0.0033
227 PNEUMOMEDIASTINUM 6 0.0033
228 HAEMATOLOGICAL INFECTION 8 0.0033
229 COLITIS ISCHAEMIC 22 0.0033
230 AZOTAEMIA 13 0.0033
231 PNEUMOPERITONEUM 6 0.0032
232 BLADDER SPASM 6 0.0032
233 BLOOD BILIRUBIN INCREASED 86 0.0032
234 BILE DUCT OBSTRUCTION 6 0.0032
235 DYSARTHRIA 119 0.0032
236 SEPTIC SHOCK 137 0.0031
237 INTESTINAL OBSTRUCTION 117 0.0031
238 ANOREXIA 40 0.0031
239 METASTASES TO MENINGES 7 0.0031
240 HYPOVOLAEMIA 18 0.0031
241 VENA CAVA THROMBOSIS 5 0.0030
242 ANORECTAL DISORDER 6 0.0030
243 DYSAESTHESIA 9 0.0029
244 ANAPHYLACTOID REACTION 12 0.0029
245 CACHEXIA 15 0.0029
246 CEREBRAL ISCHAEMIA 15 0.0029
247 VENOUS THROMBOSIS LIMB 6 0.0029
248 TONGUE DISORDER 21 0.0029
249 BLOOD MAGNESIUM DECREASED 25 0.0029
250 HYPERAMMONAEMIC ENCEPHALOPATHY 5 0.0029
251 BLOOD CREATININE DECREASED 9 0.0029
252 CYTOPENIA 35 0.0029
253 PERITONITIS 59 0.0028
254 OESOPHAGITIS 31 0.0028
255 MYELODYSPLASTIC SYNDROME 41 0.0028
256 CLOSTRIDIUM DIFFICILE COLITIS 30 0.0028
257 DEHYDRATION 376 0.0028
258 VENOUS THROMBOSIS 11 0.0028
259 DUODENAL ULCER HAEMORRHAGE 8 0.0028
260 BLOOD ALBUMIN DECREASED 22 0.0028
261 KLEBSIELLA INFECTION 14 0.0028
262 MONOPARESIS 5 0.0028
263 HEPATIC NEOPLASM 9 0.0028
264 PANCYTOPENIA 154 0.0028
265 DIARRHOEA 1759 0.0027
266 INTESTINAL ISCHAEMIA 15 0.0027
267 HYPOCALCAEMIA 51 0.0027
268 BACTERIAL TEST POSITIVE 6 0.0027
269 CARDIOTOXICITY 24 0.0027
270 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 6 0.0027
271 THROMBOCYTOPENIA 300 0.0027
272 ELECTROLYTE IMBALANCE 31 0.0027
273 LYMPHOCYTE COUNT DECREASED 47 0.0027
274 BLOOD LACTIC ACID INCREASED 14 0.0027
275 PROCTALGIA 17 0.0026
276 AREFLEXIA 7 0.0026
277 ACIDOSIS 20 0.0026
278 FEBRILE BONE MARROW APLASIA 11 0.0026
279 ABDOMINAL RIGIDITY 7 0.0026
280 HEPATIC PAIN 11 0.0026
281 HYPOPHOSPHATAEMIA 19 0.0026
282 PULMONARY INFARCTION 6 0.0025
283 PROCTITIS 7 0.0025
284 JAUNDICE 67 0.0025
285 ATELECTASIS 24 0.0025
286 DEVICE RELATED SEPSIS 5 0.0025
287 PULMONARY EMBOLISM 236 0.0025
288 SMALL INTESTINAL HAEMORRHAGE 5 0.0025
289 METASTASES TO CENTRAL NERVOUS SYSTEM 32 0.0025
290 AGRANULOCYTOSIS 46 0.0025
291 BLOOD ALKALINE PHOSPHATASE INCREASED 61 0.0025
292 LIP PAIN 7 0.0024
293 HEPATIC FUNCTION ABNORMAL 91 0.0024
294 ACUTE MYELOID LEUKAEMIA 38 0.0024
295 BLOOD PRESSURE SYSTOLIC ABNORMAL 6 0.0024
296 PYELONEPHRITIS 21 0.0024
297 PLATELET COUNT DECREASED 257 0.0024
298 PROTEIN URINE PRESENT 12 0.0024
299 PROTEIN TOTAL DECREASED 9 0.0024
300 BLEPHAROSPASM 15 0.0024
301 REGURGITATION 8 0.0023
302 PULMONARY ALVEOLAR HAEMORRHAGE 13 0.0023
303 FACIAL PALSY 5 0.0023
304 SEPSIS 256 0.0023
305 CHOLECYSTITIS ACUTE 13 0.0023
306 LEUKOCYTOSIS 41 0.0023
307 PNEUMOCYSTIS JIROVECI PNEUMONIA 5 0.0022
308 ANAL FISSURE 12 0.0022
309 RESPIRATORY RATE DECREASED 7 0.0022
310 LARGE INTESTINAL HAEMORRHAGE 5 0.0022
311 READING DISORDER 5 0.0022
312 ODYNOPHAGIA 13 0.0022
313 HAEMOLYTIC URAEMIC SYNDROME 5 0.0022
314 PERFORMANCE STATUS DECREASED 10 0.0021
315 CATHETER SITE INFECTION 8 0.0021
316 CHEMOTHERAPY 8 0.0021
317 PUSTULE 5 0.0021
318 VOLVULUS 5 0.0021
319 OESOPHAGEAL STENOSIS 6 0.0021
320 LUNG NEOPLASM 9 0.0021
321 TONGUE OEDEMA 8 0.0021
322 GASTRIC INFECTION 8 0.0021
323 MULTI-ORGAN FAILURE 36 0.0021
324 ABDOMINAL PAIN 481 0.0021
325 TUMOUR LYSIS SYNDROME 18 0.0020
326 MELAENA 45 0.0020
327 MOUTH ULCERATION 43 0.0020
328 STRIDOR 6 0.0020
329 CHEILITIS 11 0.0020
330 DEEP VEIN THROMBOSIS 132 0.0020
331 HEPATIC FAILURE 61 0.0020
332 HEMIPARESIS 34 0.0020
333 VENOOCCLUSIVE DISEASE 5 0.0020
334 ANAEMIA 380 0.0020
335 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 19 0.0020
336 DEVICE OCCLUSION 28 0.0020
337 PLATELET DISORDER 5 0.0020
338 HAEMOGLOBIN DECREASED 202 0.0020
339 CEREBRAL INFARCTION 48 0.0020
340 METASTASIS 14 0.0020
341 ASPARTATE AMINOTRANSFERASE INCREASED 104 0.0020
342 CHEST X-RAY ABNORMAL 6 0.0020
343 PNEUMONITIS 53 0.0019
344 BACTERAEMIA 23 0.0019
345 FULL BLOOD COUNT DECREASED 39 0.0019
346 WOUND INFECTION 21 0.0019
347 PSYCHOMOTOR SKILLS IMPAIRED 5 0.0019
348 PULSE ABSENT 9 0.0019
349 HYPERPYREXIA 8 0.0019
350 METASTASES TO BONE 31 0.0019
351 WHITE BLOOD CELL DISORDER 5 0.0019
352 HYPONATRAEMIA 105 0.0019
353 BLOOD SODIUM DECREASED 35 0.0019
354 VOMITING 868 0.0018
355 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 7 0.0018
356 BLOOD POTASSIUM DECREASED 55 0.0018
357 SHOCK 42 0.0018
358 DEAFNESS NEUROSENSORY 6 0.0018
359 FLANK PAIN 17 0.0018
360 FLUID INTAKE REDUCED 9 0.0018
361 DRUG TOLERANCE DECREASED 5 0.0018
362 CLOSTRIDIAL INFECTION 6 0.0018
363 DECREASED APPETITE 410 0.0018
364 VASCULAR DEVICE INFECTION 8 0.0018
365 FACIAL PARALYSIS 15 0.0018
366 ALANINE AMINOTRANSFERASE INCREASED 108 0.0018
367 OESOPHAGEAL CANDIDIASIS 7 0.0018
368 FEMORAL NECK FRACTURE 9 0.0018
369 WOUND COMPLICATION 6 0.0017
370 CANDIDIASIS 7 0.0017
371 TEMPERATURE INTOLERANCE 18 0.0017
372 SKIN DISORDER 58 0.0017
373 PARAESTHESIA ORAL 25 0.0017
374 INTERNATIONAL NORMALISED RATIO DECREASED 7 0.0017
375 GENERAL PHYSICAL HEALTH DETERIORATION 198 0.0017
376 TROPONIN INCREASED 13 0.0017
377 TYPE I HYPERSENSITIVITY 6 0.0017
378 EXTRAVASATION 7 0.0017
379 SALIVARY HYPERSECRETION 17 0.0017
380 ACUTE CORONARY SYNDROME 14 0.0017
381 SKIN FISSURES 33 0.0017
382 SUBCUTANEOUS ABSCESS 8 0.0017
383 PNEUMOTHORAX 26 0.0016
384 PYREXIA 567 0.0016
385 DYSCHEZIA 5 0.0016
386 PANCREATIC CARCINOMA 47 0.0016
387 STAPHYLOCOCCAL SEPSIS 8 0.0016
388 CHAPPED LIPS 7 0.0016
389 ABDOMINAL TENDERNESS 8 0.0016
390 STAPHYLOCOCCAL BACTERAEMIA 7 0.0016
391 ACUTE PULMONARY OEDEMA 9 0.0016
392 THERAPY PARTIAL RESPONDER 25 0.0016
393 LUNG INFILTRATION 14 0.0016
394 WHEELCHAIR USER 7 0.0016
395 BILE DUCT STONE 5 0.0016
396 HAEMATOCRIT DECREASED 31 0.0016
397 IRON DEFICIENCY 7 0.0016
398 HOSPICE CARE 15 0.0015
399 OBSTRUCTION 6 0.0015
400 GASTRITIS EROSIVE 7 0.0015
401 PNEUMOCYSTIS JIROVECII PNEUMONIA 15 0.0015
402 URINE OUTPUT DECREASED 13 0.0015
403 TONGUE ULCERATION 5 0.0015
404 NEOPLASM 17 0.0015
405 SINUS TACHYCARDIA 21 0.0015
406 NEOPLASM RECURRENCE 5 0.0015
407 HAEMATEMESIS 37 0.0015
408 MULTIPLE ORGAN DYSFUNCTION SYNDROME 41 0.0014
409 RED CELL DISTRIBUTION WIDTH INCREASED 6 0.0014
410 THROMBOPHLEBITIS 5 0.0014
411 PANCREATITIS ACUTE 32 0.0014
412 MUSCLE CONTRACTIONS INVOLUNTARY 5 0.0014
413 FACIAL PARESIS 5 0.0014
414 GLOSSITIS 5 0.0014
415 PULMONARY TUBERCULOSIS 6 0.0014
416 CONJUNCTIVAL HYPERAEMIA 5 0.0014
417 ASTHENIA 525 0.0014
418 BLOOD CREATININE INCREASED 91 0.0014
419 HEPATOTOXICITY 31 0.0014
420 DIARRHOEA HAEMORRHAGIC 13 0.0014
421 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 7 0.0014
422 FEEDING DISORDER 28 0.0014
423 REFUSAL OF TREATMENT BY PATIENT 9 0.0014
424 PHLEBITIS 7 0.0014
425 ORAL CANDIDIASIS 18 0.0014
426 FOOD INTOLERANCE 5 0.0014
427 SPEECH DISORDER 71 0.0014
428 SKIN NECROSIS 7 0.0013
429 C-REACTIVE PROTEIN INCREASED 49 0.0013
430 RESPIRATORY FAILURE 98 0.0013
431 TACHYCARDIA 119 0.0013
432 PROTHROMBIN TIME PROLONGED 8 0.0013
433 DERMATITIS 28 0.0013
434 SPINAL COMPRESSION FRACTURE 11 0.0013
435 SUDDEN DEATH 14 0.0013
436 OFF LABEL USE 1156 0.0013
437 HAEMODYNAMIC INSTABILITY 10 0.0013
438 ANAL FISTULA 7 0.0013
439 GAMMA-GLUTAMYLTRANSFERASE INCREASED 29 0.0013
440 COMPRESSION FRACTURE 7 0.0013
441 MUSCLE TWITCHING 30 0.0013
442 CHRONIC MYELOID LEUKAEMIA 6 0.0013
443 RENAL FAILURE ACUTE 55 0.0013
444 OSTEONECROSIS OF JAW 32 0.0013
445 HEPATIC ENCEPHALOPATHY 12 0.0013
446 RHINOVIRUS INFECTION 5 0.0013
447 SPINAL CORD COMPRESSION 5 0.0013
448 INFUSION RELATED REACTION 85 0.0013
449 EPIGASTRIC DISCOMFORT 5 0.0013
450 PAPULE 9 0.0013
451 FAECALOMA 7 0.0013
452 PULMONARY MASS 19 0.0013
453 GASTRIC ULCER HAEMORRHAGE 7 0.0013
454 COAGULOPATHY 21 0.0013
455 TRANSAMINASES INCREASED 28 0.0013
456 CHOLECYSTITIS 15 0.0013
457 HYPERTENSIVE CRISIS 14 0.0013
458 APHASIA 38 0.0013
459 NAIL DISORDER 11 0.0013
460 EPISTAXIS 94 0.0013
461 FISTULA 14 0.0012
462 BLOOD CALCIUM DECREASED 14 0.0012
463 PURPURA 11 0.0012
464 ENTEROCOCCAL INFECTION 6 0.0012
465 CYSTITIS HAEMORRHAGIC 5 0.0012
466 HAEMATOCHEZIA 68 0.0012
467 SHOCK HAEMORRHAGIC 10 0.0012
468 RECURRENT CANCER 5 0.0012
469 PERIPHERAL ISCHAEMIA 5 0.0012
470 RED BLOOD CELL COUNT DECREASED 35 0.0012
471 EJECTION FRACTION DECREASED 19 0.0012
472 DEMYELINATION 5 0.0012
473 NAUSEA 964 0.0012
474 OROPHARYNGEAL DISCOMFORT 11 0.0012
475 HEPARIN-INDUCED THROMBOCYTOPENIA 6 0.0012
476 ESCHERICHIA INFECTION 10 0.0012
477 HYPERVENTILATION 7 0.0012
478 HEMIPLEGIA 10 0.0012
479 LYMPHOPENIA 17 0.0012
480 CARDIAC FAILURE ACUTE 8 0.0012
481 BLOOD LACTATE DEHYDROGENASE INCREASED 19 0.0012
482 UROSEPSIS 11 0.0012
483 NERVE COMPRESSION 11 0.0012
484 CONJUNCTIVITIS 22 0.0012
485 ENCEPHALOPATHY 29 0.0012
486 HYPERTHERMIA 9 0.0012
487 AMMONIA INCREASED 6 0.0012
488 AORTIC VALVE INCOMPETENCE 5 0.0012
489 PETIT MAL EPILEPSY 6 0.0012
490 VENTRICULAR FIBRILLATION 13 0.0012
491 HYPERKALAEMIA 41 0.0012
492 RECTAL HAEMORRHAGE 50 0.0012
493 TRISMUS 6 0.0012
494 PNEUMONIA ASPIRATION 29 0.0012
495 HORDEOLUM 5 0.0012
496 MONOPLEGIA 5 0.0011
497 DRUG-INDUCED LIVER INJURY 36 0.0011
498 LIVER INJURY 28 0.0011
499 SKIN REACTION 16 0.0011
500 PIGMENTATION DISORDER 7 0.0011
501 HYPOAESTHESIA ORAL 17 0.0011
502 RENAL TUBULAR NECROSIS 11 0.0011
503 HEPATOMEGALY 11 0.0011
504 BODY TEMPERATURE DECREASED 11 0.0011
505 URINARY TRACT DISORDER 5 0.0011
506 URINARY RETENTION 37 0.0011
507 GASTRIC ULCER 21 0.0011
508 CLOSTRIDIUM DIFFICILE INFECTION 24 0.0011
509 WHITE BLOOD CELL COUNT ABNORMAL 7 0.0011
510 HYPOTENSION 220 0.0011
511 ASPIRATION 12 0.0011
512 TOXIC SKIN ERUPTION 11 0.0011
513 IMMUNE THROMBOCYTOPENIA 5 0.0011
514 HAEMOGLOBIN ABNORMAL 7 0.0011
515 AMYLASE INCREASED 4 0.0011
516 DEATH 933 0.0011
517 LOWER GASTROINTESTINAL HAEMORRHAGE 8 0.0011
518 HYPOXIA 38 0.0011
519 GASTROINTESTINAL HAEMORRHAGE 90 0.0011
520 BLOOD UREA INCREASED 18 0.0011
521 PRODUCT USE IN UNAPPROVED INDICATION 266 0.0011
522 THROMBOSIS 86 0.0011
523 PLEURAL EFFUSION 65 0.0011
524 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
525 EXERCISE TOLERANCE DECREASED 6 0.0010
526 GUILLAIN-BARRE SYNDROME 5 0.0010
527 TACHYPNOEA 14 0.0010
528 CONSTIPATION 222 0.0010
529 ONYCHOCLASIS 7 0.0010
530 CHILLS 119 0.0010
531 DROOLING 7 0.0010
532 HYPERVOLAEMIA 5 0.0010
533 UPPER GASTROINTESTINAL HAEMORRHAGE 17 0.0010
534 HAEMOLYTIC ANAEMIA 9 0.0010
535 HYPERNATRAEMIA 5 0.0010
536 ATRIAL FLUTTER 8 0.0010
537 BLOOD TEST ABNORMAL 14 0.0010
538 PLATELET COUNT ABNORMAL 6 0.0010
539 PNEUMONIA BACTERIAL 9 0.0010
540 ACUTE KIDNEY INJURY 150 0.0010
541 GENERALISED OEDEMA 12 0.0010
542 ALTERED STATE OF CONSCIOUSNESS 21 0.0010
543 DERMATITIS BULLOUS 7 0.0010
544 MYOCARDIAL ISCHAEMIA 11 0.0010
545 VENTRICULAR EXTRASYSTOLES 10 0.0010
546 FAECES SOFT 7 0.0010
547 TRANSFUSION 10 0.0010
548 DRUG TOXICITY 13 0.0010
549 ABDOMINAL PAIN LOWER 24 0.0009
550 DYSPHAGIA 90 0.0009
551 SERUM FERRITIN INCREASED 5 0.0009
552 CARDIOMYOPATHY 14 0.0009
553 NYSTAGMUS 5 0.0009
554 PULMONARY FIBROSIS 18 0.0009
555 METABOLIC ACIDOSIS 30 0.0009
556 ORAL PAIN 21 0.0009
557 HYPERTENSION 198 0.0009
558 MASS 13 0.0009
559 ANURIA 8 0.0009
560 ANAL ABSCESS 5 0.0009
561 INCOHERENT 6 0.0009
562 ANGINA UNSTABLE 6 0.0009
563 LETHARGY 53 0.0009
564 ORTHOSTATIC HYPOTENSION 16 0.0009
565 BOWEL MOVEMENT IRREGULARITY 7 0.0009
566 NEOPLASM MALIGNANT 61 0.0009
567 LIPASE INCREASED 7 0.0009
568 JAW DISORDER 5 0.0009
569 BRONCHOSPASM 13 0.0009
570 VENTRICULAR TACHYCARDIA 15 0.0009
571 DYSPHONIA 53 0.0009
572 HYPERGLYCAEMIA 33 0.0009
573 NO THERAPEUTIC RESPONSE 11 0.0009
574 RESPIRATORY RATE INCREASED 8 0.0009
575 INFECTION 130 0.0009
576 GASTROINTESTINAL INFLAMMATION 7 0.0009
577 GASTROINTESTINAL INFECTION 8 0.0009
578 ANGIOPATHY 5 0.0009
579 ABDOMINAL DISTENSION 93 0.0009
580 ANAL INCONTINENCE 8 0.0009
581 POSTOPERATIVE WOUND INFECTION 6 0.0009
582 IMPAIRED HEALING 29 0.0009
583 PALLOR 24 0.0009
584 CIRCULATORY COLLAPSE 15 0.0009
585 IMPAIRED GASTRIC EMPTYING 12 0.0009
586 NEUTROPHIL COUNT INCREASED 9 0.0009
587 HAEMATURIA 30 0.0009
588 NEUROLOGICAL SYMPTOM 5 0.0009
589 PERIPHERAL COLDNESS 12 0.0009
590 RESPIRATORY DISTRESS 24 0.0009
591 WHITE BLOOD CELL COUNT INCREASED 33 0.0009
592 DEPRESSED LEVEL OF CONSCIOUSNESS 34 0.0009
593 COLORECTAL CANCER 41 0.0009
594 APPENDICITIS 8 0.0009
595 DEFAECATION URGENCY 6 0.0009
596 ABNORMAL FAECES 7 0.0009
597 SPLENOMEGALY 10 0.0009
598 FULL BLOOD COUNT ABNORMAL 9 0.0009
599 OEDEMA 46 0.0008
600 DRUG ERUPTION 15 0.0008
601 PARAESTHESIA 133 0.0008
602 TASTE DISORDER 17 0.0008
603 DELIRIUM 29 0.0008
604 SARS-COV-2 TEST POSITIVE 11 0.0008
605 HEPATITIS CHOLESTATIC 5 0.0008
606 GASTROENTERITIS 12 0.0008
607 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 5 0.0008
608 VITAMIN D DEFICIENCY 8 0.0008
609 ULCER 13 0.0008
610 HEPATIC STEATOSIS 15 0.0008
611 SKIN INFECTION 9 0.0008
612 GASTRITIS 21 0.0008
613 RETCHING 17 0.0008
614 STAPHYLOCOCCAL INFECTION 26 0.0008
615 GASTRIC HAEMORRHAGE 9 0.0008
616 CEREBRAL HAEMORRHAGE 28 0.0008
617 CHOLESTASIS 15 0.0008
618 POST PROCEDURAL COMPLICATION 15 0.0008
619 FATIGUE 608 0.0008
620 ACUTE RESPIRATORY FAILURE 15 0.0008
621 LUNG DISORDER 38 0.0008
622 BRONCHOPULMONARY ASPERGILLOSIS 6 0.0008
623 WEIGHT DECREASED 216 0.0008
624 RENAL IMPAIRMENT 65 0.0008
625 PRODUCT USE ISSUE 145 0.0008
626 APNOEA 6 0.0008
627 SWOLLEN TONGUE 24 0.0008
628 TENDERNESS 8 0.0008
629 PULMONARY HAEMORRHAGE 6 0.0008
630 CARDIOGENIC SHOCK 11 0.0008
631 IMPAIRED QUALITY OF LIFE 11 0.0008
632 ELECTROCARDIOGRAM ABNORMAL 6 0.0008
633 RASH MACULO-PAPULAR 17 0.0008
634 CYANOSIS 12 0.0008
635 LACRIMATION INCREASED 23 0.0008
636 ATRIAL FIBRILLATION 74 0.0008
637 DYSGRAPHIA 5 0.0008
638 MENTAL STATUS CHANGES 21 0.0008
639 MENINGITIS 5 0.0007
640 LIVER FUNCTION TEST INCREASED 16 0.0007
641 THROAT TIGHTNESS 20 0.0007
642 PANCREATITIS 39 0.0007
643 GENERAL PHYSICAL CONDITION ABNORMAL 5 0.0007
644 ANAPHYLACTIC SHOCK 19 0.0007
645 ACUTE RESPIRATORY DISTRESS SYNDROME 13 0.0007
646 CHOLELITHIASIS 24 0.0007
647 DISORIENTATION 29 0.0007
648 SUPRAVENTRICULAR TACHYCARDIA 7 0.0007
649 HYPERHIDROSIS 94 0.0007
650 HYPERCALCAEMIA 9 0.0007
651 GASTROINTESTINAL PAIN 8 0.0007
652 LIVER FUNCTION TEST ABNORMAL 21 0.0007
653 LIVER DISORDER 32 0.0007
654 HAEMORRHOIDS 14 0.0007
655 DYSPNOEA EXERTIONAL 27 0.0007
656 ACUTE MYOCARDIAL INFARCTION 21 0.0007
657 VITREOUS FLOATERS 7 0.0007
658 CANDIDA INFECTION 12 0.0007
659 DYSURIA 26 0.0007
660 BRAIN FOG 11 0.0007
661 CHEST DISCOMFORT 71 0.0007
662 BLOOD CALCIUM INCREASED 6 0.0007
663 HAEMOPTYSIS 19 0.0007
664 MUSCULAR WEAKNESS 77 0.0007
665 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
666 ARRHYTHMIA 32 0.0007
667 PETECHIAE 7 0.0007
668 IMMUNODEFICIENCY 10 0.0007
669 PNEUMONIA 217 0.0007
670 FOLLICULITIS 7 0.0007
671 INTERNATIONAL NORMALISED RATIO INCREASED 19 0.0007
672 ORAL HERPES 13 0.0007
673 CONVULSION 38 0.0007
674 INCONTINENCE 7 0.0007
675 DRUG RESISTANCE 17 0.0007
676 GINGIVAL BLEEDING 9 0.0007
677 EATING DISORDER 14 0.0007
678 CELLULITIS 33 0.0007
679 BRAIN NEOPLASM 6 0.0007
680 IRON DEFICIENCY ANAEMIA 6 0.0006
681 LYMPHADENOPATHY 23 0.0006
682 DIVERTICULITIS 18 0.0006
683 LACTIC ACIDOSIS 21 0.0006
684 ORAL DISCOMFORT 9 0.0006
685 PULMONARY OEDEMA 29 0.0006
686 FAECES DISCOLOURED 14 0.0006
687 APHTHOUS ULCER 5 0.0006
688 BACTERIAL INFECTION 12 0.0006
689 PELVIC FRACTURE 5 0.0006
690 URINARY INCONTINENCE 19 0.0006
691 ABDOMINAL PAIN UPPER 132 0.0006
692 BODY TEMPERATURE INCREASED 13 0.0006
693 LEUKAEMIA 6 0.0006
694 RHINORRHOEA 41 0.0006
695 ANAPHYLACTIC REACTION 35 0.0006
696 PARALYSIS 9 0.0006
697 GINGIVAL PAIN 5 0.0006
698 COLD SWEAT 11 0.0006
699 OXYGEN SATURATION DECREASED 35 0.0006
700 ERUCTATION 12 0.0006
701 DIZZINESS POSTURAL 6 0.0006
702 MITRAL VALVE INCOMPETENCE 7 0.0006
703 FLUSHING 62 0.0006
704 OEDEMA PERIPHERAL 74 0.0006
705 PERICARDIAL EFFUSION 14 0.0006
706 MALAISE 264 0.0006
707 HYPOAESTHESIA 90 0.0006
708 CARDIO-RESPIRATORY ARREST 25 0.0006
709 EMPHYSEMA 6 0.0006
710 CARDIAC ARREST 49 0.0006
711 ALOPECIA 116 0.0006
712 ATAXIA 7 0.0006
713 MOTOR DYSFUNCTION 6 0.0006
714 BLOOD PRESSURE DECREASED 39 0.0006
715 MUSCLE RIGIDITY 7 0.0006
716 GASTROINTESTINAL DISORDER 52 0.0006
717 SKIN ULCER 15 0.0006
718 RENAL FAILURE 77 0.0006
719 LUNG INFECTION 9 0.0006
720 DIPLOPIA 15 0.0006
721 EYE DISCHARGE 6 0.0006
722 NERVOUS SYSTEM DISORDER 18 0.0006
723 TOXICITY TO VARIOUS AGENTS 97 0.0006
724 CARDIOMEGALY 7 0.0006
725 GAIT INABILITY 19 0.0006
726 IMMUNOSUPPRESSION 5 0.0006
727 DRY SKIN 75 0.0006
728 THROAT IRRITATION 25 0.0006
729 EPILEPSY 17 0.0006
730 BLOOD PRESSURE INCREASED 85 0.0006
731 BRAIN OEDEMA 7 0.0006
732 RASH 241 0.0006
733 TOOTHACHE 10 0.0006
734 CONFUSIONAL STATE 89 0.0006
735 DYSPEPSIA 54 0.0005
736 PATHOGEN RESISTANCE 5 0.0005
737 CARDIAC FAILURE 44 0.0005
738 DYSSTASIA 16 0.0005
739 URINARY TRACT INFECTION 93 0.0005
740 DIABETIC KETOACIDOSIS 13 0.0005
741 ACNE 41 0.0005
742 DYSPNOEA 304 0.0005
743 PLATELET COUNT INCREASED 7 0.0005
744 NODULE 7 0.0005
745 ERYTHEMA MULTIFORME 5 0.0005
746 HAEMORRHAGE INTRACRANIAL 8 0.0005
747 BACK PAIN 124 0.0005
748 FLATULENCE 30 0.0005
749 HYPERSENSITIVITY 98 0.0005
750 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 37 0.0005
751 SYNCOPE 52 0.0005
752 FREQUENT BOWEL MOVEMENTS 14 0.0005
753 SINUS BRADYCARDIA 5 0.0005
754 HAEMORRHAGE 54 0.0005
755 RASH MACULAR 18 0.0005
756 SKIN LESION 14 0.0005
757 DISCOMFORT 31 0.0005
758 RESPIRATORY ARREST 14 0.0005
759 ISCHAEMIC STROKE 9 0.0005
760 TRANSIENT ISCHAEMIC ATTACK 17 0.0005
761 RASH GENERALISED 13 0.0005
762 ABSCESS 8 0.0005
763 OSTEOMYELITIS 9 0.0005
764 ADRENAL INSUFFICIENCY 6 0.0005
765 HYPOTHERMIA 5 0.0005
766 BLOOD POTASSIUM INCREASED 8 0.0005
767 EYELID PTOSIS 5 0.0005
768 RASH PAPULAR 11 0.0005
769 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 5 0.0005
770 CHEST PAIN 90 0.0005
771 ERYTHEMA 99 0.0005
772 FACE OEDEMA 8 0.0005
773 SCRATCH 5 0.0005
774 HEPATIC CYTOLYSIS 6 0.0005
775 RESPIRATORY DISORDER 14 0.0005
776 WOUND 13 0.0005
777 UNRESPONSIVE TO STIMULI 12 0.0005
778 DECREASED ACTIVITY 5 0.0005
779 LOSS OF CONSCIOUSNESS 59 0.0005
780 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 22 0.0005
781 HEPATIC ENZYME INCREASED 31 0.0005
782 ANGINA PECTORIS 13 0.0005
783 HYPOGLYCAEMIA 22 0.0005
784 BRADYCARDIA 24 0.0005
785 HERPES ZOSTER 26 0.0005
786 DISEASE RECURRENCE 21 0.0004
787 SCAB 5 0.0004
788 MICTURITION URGENCY 5 0.0004
789 GASTROOESOPHAGEAL REFLUX DISEASE 35 0.0004
790 FEELING COLD 12 0.0004
791 ANGIOEDEMA 19 0.0004
792 DRUG INTOLERANCE 41 0.0004
793 COVID-19 PNEUMONIA 5 0.0004
794 OROPHARYNGEAL PAIN 39 0.0004
795 THERAPY CESSATION 21 0.0004
796 SEIZURE 47 0.0004
797 INJECTION SITE EXTRAVASATION 5 0.0004
798 CEREBROVASCULAR ACCIDENT 68 0.0004
799 CHROMATURIA 9 0.0004
800 DERMATITIS ALLERGIC 5 0.0004
801 THERAPEUTIC RESPONSE DECREASED 24 0.0004
802 MUSCLE SPASMS 72 0.0004
803 HEPATITIS 10 0.0004
804 PAIN IN JAW 11 0.0004
805 ABDOMINAL DISCOMFORT 65 0.0004
806 BONE DISORDER 7 0.0004
807 PULMONARY HYPERTENSION 8 0.0004
808 DEAFNESS 10 0.0004
809 BEDRIDDEN 5 0.0004
810 TREMOR 63 0.0004
811 SCIATICA 6 0.0004
812 FEELING HOT 23 0.0004
813 MOVEMENT DISORDER 12 0.0004
814 HEPATIC CIRRHOSIS 7 0.0004
815 BLOOD URINE PRESENT 7 0.0004
816 COGNITIVE DISORDER 17 0.0004
817 CENTRAL NERVOUS SYSTEM LESION 5 0.0004
818 PHOTOSENSITIVITY REACTION 6 0.0004
819 HERNIA 7 0.0004
820 COORDINATION ABNORMAL 5 0.0004
821 COMA 17 0.0004
822 DIZZINESS 178 0.0004
823 SNEEZING 8 0.0004
824 RASH ERYTHEMATOUS 17 0.0004
825 GASTRIC CANCER 9 0.0004
826 HEPATOCELLULAR INJURY 5 0.0004
827 INFLAMMATION 18 0.0003
828 BLOOD CREATINE PHOSPHOKINASE INCREASED 10 0.0003
829 CYSTITIS 11 0.0003
830 HYPOKINESIA 5 0.0003
831 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
832 PAIN 210 0.0003
833 LABORATORY TEST ABNORMAL 10 0.0003
834 SOMNOLENCE 68 0.0003
835 OESOPHAGEAL CARCINOMA 10 0.0003
836 PRODUCT PRESCRIBING ERROR 8 0.0003
837 CONDITION AGGRAVATED 102 0.0003
838 PAIN OF SKIN 9 0.0003
839 FALL 111 0.0003
840 INTENTIONAL PRODUCT USE ISSUE 29 0.0003
841 PELVIC PAIN 6 0.0003
842 BLOOD COUNT ABNORMAL 5 0.0003
843 DEVICE FAILURE 5 0.0003
844 RESTLESSNESS 12 0.0003
845 UPPER RESPIRATORY TRACT INFECTION 15 0.0003
846 FRACTURE 6 0.0003
847 PALPITATIONS 37 0.0003
848 GLOSSODYNIA 7 0.0003
849 VERTIGO 19 0.0003
850 RHABDOMYOLYSIS 13 0.0003
851 SENSORY DISTURBANCE 5 0.0003
852 DYSGEUSIA 23 0.0003
853 SWELLING FACE 20 0.0003
854 PSYCHOTIC DISORDER 9 0.0003
855 SKIN DISCOLOURATION 14 0.0003
856 OSTEONECROSIS 10 0.0003
857 HEART RATE INCREASED 30 0.0003
858 BLOOD PRESSURE ABNORMAL 6 0.0003
859 UPPER LIMB FRACTURE 6 0.0003
860 RENAL DISORDER 14 0.0003
861 CYTOKINE RELEASE SYNDROME 6 0.0003
862 ILL-DEFINED DISORDER 18 0.0003
863 PRURITUS 113 0.0003
864 ACUTE HEPATIC FAILURE 4 0.0003
865 VISUAL IMPAIRMENT 36 0.0003
866 MUSCULOSKELETAL DISCOMFORT 5 0.0003
867 MENTAL IMPAIRMENT 7 0.0003
868 EOSINOPHILIA 5 0.0003
869 AMENORRHOEA 5 0.0003
870 SKIN EXFOLIATION 24 0.0003
871 DRUG INTERACTION 45 0.0003
872 NEPHROLITHIASIS 13 0.0003
873 URTICARIA 47 0.0003
874 HYPERSOMNIA 8 0.0003
875 TREATMENT FAILURE 23 0.0003
876 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 8 0.0003
877 PRODUCTIVE COUGH 13 0.0003
878 ADVERSE EVENT 25 0.0003
879 STEVENS-JOHNSON SYNDROME 6 0.0003
880 COUGH 75 0.0003
881 CARDIAC DISORDER 25 0.0003
882 BLISTER 15 0.0003
883 THERAPY NON-RESPONDER 12 0.0003
884 TUBULOINTERSTITIAL NEPHRITIS 5 0.0003
885 GAIT DISTURBANCE 51 0.0003
886 DIABETES MELLITUS 20 0.0003
887 PERIPHERAL SWELLING 40 0.0003
888 SWELLING 24 0.0003
889 HEART RATE DECREASED 9 0.0003
890 MUSCULOSKELETAL PAIN 13 0.0002
891 NEURALGIA 6 0.0002
892 MYOCARDIAL INFARCTION 43 0.0002
893 RASH PRURITIC 13 0.0002
894 TINNITUS 11 0.0002
895 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 13 0.0002
896 DRY MOUTH 19 0.0002
897 COVID-19 40 0.0002
898 THERAPY INTERRUPTED 16 0.0002
899 BONE PAIN 13 0.0002
900 HEAD INJURY 7 0.0002
901 LOWER RESPIRATORY TRACT INFECTION 10 0.0002
902 VISION BLURRED 30 0.0002
903 POLLAKIURIA 9 0.0002
904 DRUG INEFFECTIVE 284 0.0002
905 VISUAL ACUITY REDUCED 7 0.0002
906 VIRAL INFECTION 7 0.0002
907 DEPRESSED MOOD 11 0.0002
908 PAIN IN EXTREMITY 61 0.0002
909 DEVICE DISLOCATION 9 0.0002
910 GASTRIC DISORDER 7 0.0002
911 MEDICATION ERROR 11 0.0002
912 DRUG ADMINISTRATION ERROR 6 0.0002
913 LUNG NEOPLASM MALIGNANT 8 0.0002
914 JOINT STIFFNESS 5 0.0002
915 HEADACHE 118 0.0002
916 HIP FRACTURE 6 0.0002
917 HOT FLUSH 14 0.0002
918 OVERDOSE 40 0.0002
919 BALANCE DISORDER 16 0.0002
920 AMNESIA 12 0.0002
921 VAGINAL HAEMORRHAGE 8 0.0002
922 TREATMENT NONCOMPLIANCE 10 0.0002
923 DRY EYE 9 0.0002
924 FEELING ABNORMAL 43 0.0002
925 UNDERDOSE 13 0.0002
926 ANXIETY 50 0.0002
927 DYSKINESIA 7 0.0002
928 SURGERY 10 0.0002
929 OSTEOPOROSIS 7 0.0002
930 CATARACT 10 0.0002
931 MEMORY IMPAIRMENT 23 0.0002
932 ELECTROCARDIOGRAM QT PROLONGED 6 0.0002
933 PREMATURE BABY 5 0.0002
934 DRUG EFFECT INCOMPLETE 6 0.0002
935 EMOTIONAL DISORDER 5 0.0002
936 LIMB DISCOMFORT 5 0.0002
937 FEMUR FRACTURE 5 0.0002
938 AGEUSIA 4 0.0002
939 HALLUCINATION 12 0.0002
940 BLOOD GLUCOSE INCREASED 30 0.0002
941 NASOPHARYNGITIS 29 0.0002
942 FLUID RETENTION 8 0.0002
943 COLITIS ULCERATIVE 7 0.0002
944 HYPOTHYROIDISM 5 0.0002
945 NIGHT SWEATS 5 0.0002
946 ECZEMA 8 0.0002
947 WHEEZING 9 0.0002
948 LIP SWELLING 5 0.0001
949 FUNGAL INFECTION 5 0.0001
950 CARDIAC FAILURE CONGESTIVE 12 0.0001
951 DRUG EFFECT DECREASED 8 0.0001
952 ILLNESS 15 0.0001
953 ROAD TRAFFIC ACCIDENT 6 0.0001
954 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 10 0.0001
955 MENTAL DISORDER 6 0.0001
956 INFLUENZA 15 0.0001
957 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 7 0.0001
958 BURNING SENSATION 9 0.0001
959 OCULAR HYPERAEMIA 6 0.0001
960 CONTUSION 12 0.0001
961 EYE PAIN 7 0.0001
962 INSOMNIA 33 0.0001
963 BLINDNESS 5 0.0001
964 ARTHRALGIA 51 0.0001
965 BRONCHITIS 9 0.0001
966 HOSPITALISATION 18 0.0001
967 HYPOACUSIS 5 0.0001
968 WEIGHT INCREASED 25 0.0001
969 MOBILITY DECREASED 8 0.0001
970 DISTURBANCE IN ATTENTION 6 0.0001
971 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 20 0.0001
972 SKIN IRRITATION 5 0.0001
973 AGITATION 8 0.0001
974 NECK PAIN 6 0.0001
975 MIGRAINE 10 0.0001
976 NASAL CONGESTION 6 0.0001
977 ADVERSE DRUG REACTION 9 0.0001
978 IRRITABILITY 6 0.0001
979 JOINT SWELLING 12 0.0001
980 SINUSITIS 10 0.0001
981 NERVOUSNESS 5 0.0001
982 DEPRESSION 21 0.0001
983 EYE IRRITATION 5 0.0001
984 SLEEP DISORDER 6 0.0001
985 AGGRESSION 4 0.0001
986 MUSCULOSKELETAL STIFFNESS 7 0.0001
987 UNEVALUABLE EVENT 6 0.0001
988 MYALGIA 13 0.0001
989 PRODUCT QUALITY ISSUE 10 0.0001
990 NO ADVERSE EVENT 13 0.0001
991 PRODUCT DOSE OMISSION ISSUE 21 0.0001
992 MATERNAL EXPOSURE DURING PREGNANCY 6 0.0001
993 ASTHMA 7 0.0001
994 PRODUCT STORAGE ERROR 5 0.0001
995 DRUG DOSE OMISSION 9 0.0001
996 INCORRECT DOSE ADMINISTERED 9 0.0000